The US Rare Neurological Disease Treatment Market represents a key component of the global landscape because of its advanced clinical research ecosystem, concentration of leading pharmaceutical companies, and strong government and institutional support for rare disease drug development. The US Food and Drug Administration (FDA) has introduced initiatives supporting scientific and regulatory...